Pain Relief Patches

Description

The product is identified by the SPL code 34089-3 and is classified as a pain relief patch. It is recommended to store the patch in a clean, dry environment, away from direct sunlight, and to protect it from excessive moisture to maintain its efficacy.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 12 years and over, the affected area should be cleaned and dried prior to application. The patch should be removed from its protective film and applied to the affected area. It is recommended that the patch be applied no more than 3 to 4 times daily. Each patch should be removed from the skin after a maximum application duration of 8 hours.

For children under 12 years of age, it is advised to consult a physician before use.

Contraindications

Use of this product is contraindicated in individuals with a known allergy to any of its ingredients.

Application is not recommended on wounds or damaged skin due to the potential for irritation and delayed healing. The use of a heating pad in conjunction with this product is also contraindicated, as it may increase the risk of adverse effects.

While using this product, it is essential to avoid contact with the eyes, mucous membranes, or rashes to prevent irritation. Additionally, do not apply tight bandages over the treated area, and refrain from using other topical analgesics simultaneously, as this may lead to increased systemic absorption and potential toxicity.

Warnings and Precautions

Patients with a known allergy to aspirin or salicylates should consult a healthcare professional prior to use to mitigate the risk of an allergic reaction.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Healthcare providers should advise patients to discontinue use and seek medical attention if they experience any of the following: the development of a rash, itching, or excessive skin irritation; worsening of their condition; or if symptoms persist beyond 7 days or resolve only to recur within a few days.

Side Effects

Patients should be aware of the potential for allergic reactions, particularly if they have a history of sensitivity to aspirin or salicylates. It is advisable for these individuals to consult a healthcare professional prior to use.

In the event that patients experience a rash, itching, or excessive skin irritation, they should discontinue use and seek medical advice. Additionally, if the condition worsens or if symptoms persist for more than seven days, or if they resolve only to recur within a few days, it is important to consult a doctor. These recommendations are crucial for ensuring patient safety and effective management of any adverse reactions that may arise during treatment.

Drug Interactions

Concurrent use of this medication with other topical analgesics is contraindicated. The combination may increase the risk of adverse effects without providing additional therapeutic benefit. It is advised to avoid using multiple topical analgesics simultaneously to ensure patient safety and optimal therapeutic outcomes. Monitoring for any signs of increased local irritation or systemic effects is recommended if there is a concern for inadvertent overlap in therapy.

Packaging & NDC

Below are the non-prescription pack sizes of Pain Relief Patches (camphor, menthol, methyl salicylate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a physician prior to use. It is essential to keep the product out of reach of children, as used patches still contain the drug and can pose serious risks if chewed or ingested. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

For patients aged 12 years and older, the recommended application involves cleaning and drying the affected area before applying the patch. The patch should be applied to the affected area no more than 3 to 4 times daily and should be removed after a maximum of 8 hours. Proper disposal of used patches is crucial to prevent accidental exposure to children and pets.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The safety of this product during pregnancy has not been established. Pregnant patients or those planning to become pregnant should consult a physician before use. Potential risks to the fetus are not clearly defined; therefore, caution is advised. There are no specific dosage modifications for pregnant individuals provided in the prescribing information. This product should only be used if clearly needed and after consultation with a healthcare provider.

Lactation

Lactating mothers should consult a doctor before using this product. There is a potential for excretion in breast milk, and the safety of this product during lactation has not been established. Caution is advised when using this product while breastfeeding.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific information regarding overdosage, it is important for healthcare professionals to remain vigilant and consider the potential implications of excessive dosing of the medication in question.

Healthcare providers should be aware that symptoms of overdosage may vary depending on the pharmacological properties of the drug. In cases where overdosage is suspected, it is recommended to monitor the patient closely for any adverse effects or unusual symptoms that may arise.

Management of overdosage should be guided by the clinical presentation of the patient. Supportive care is essential, and healthcare professionals should implement appropriate interventions based on the severity of symptoms. In situations where specific antidotes or treatments are available, these should be administered as indicated.

It is advisable for healthcare professionals to consult relevant clinical guidelines or poison control resources for further information on the management of overdosage, including any specific recommendations for the drug in question.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Postmarketing experience has identified the following adverse reactions: rash, itching, and excessive skin irritation. Additionally, serious adverse effects may occur if a child or pet chews or ingests a used patch. These events have been reported voluntarily or through surveillance programs.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to instruct patients not to apply the product on wounds or damaged skin, and to avoid using it in conjunction with a heating pad.

Patients should be informed that they must not use the product if they have a known allergy to any of its ingredients. They should be counseled to discontinue use and consult a doctor if they experience rash, itching, or excessive skin irritation. Additionally, patients should be advised to stop using the product and seek medical advice if their condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days.

Healthcare providers should emphasize the importance of using the product only as directed and to avoid contact with eyes, mucous membranes, or rashes. Patients should be cautioned against tightly bandaging the area where the product is applied and should not use it simultaneously with other topical analgesics.

Finally, it is crucial to instruct patients on the proper disposal of used patches, ensuring they are kept out of reach of children and pets, as these patches may still contain active drug that could lead to serious adverse effects if ingested.

Storage and Handling

The product is supplied in a clean, dry package designed to protect it from direct sunlight and excessive moisture. It is essential to store the product in a location that maintains these conditions to ensure its integrity and effectiveness.

After use, the patch must be disposed of properly to prevent access by children and pets, ensuring safety in the environment.

Additional Clinical Information

The route of administration for the product is topical. For adults and children aged 12 years and older, the affected area should be cleaned and dried before applying the patch, which can be used no more than 3 to 4 times daily. The patch should be removed after a maximum application time of 8 hours. For children under 12 years of age, consultation with a physician is advised.

Clinicians should counsel patients on several important safety measures. Individuals with a history of allergic reactions to aspirin or salicylates should consult a doctor prior to use. Used patches must be disposed of properly to prevent access by children and pets, as they still contain active drug that could lead to serious adverse effects if ingested. Patients should discontinue use and seek medical advice if they experience rash, itching, excessive skin irritation, worsening of their condition, or if symptoms persist beyond 7 days or recur shortly after resolution. Additionally, the product should be kept out of reach of children, and immediate medical assistance should be sought if swallowed.

Drug Information (PDF)

This file contains official product information for Pain Relief Patches, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)